Literature DB >> 7044087

The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).

J Kluger, R J Cody, J H Laragh.   

Abstract

The contribution of sympathetic tone and the renin-angiotensin system to the pathogenesis of chronic heart failure was evaluated. In 20 paired studies of the same 10 patients, the baseline hemodynamic and humoral correlates of congestive heart failure, and the response to alpha adrenergic blockade (prazosin) and angiotensin converting enzyme inhibition (captopril) were assessed. Despite the extent of failure, baseline plasma renin activity ranged from normal to very high. In contrast, baseline plasma catecholamine levels were always elevated. Baseline plasma norepinephrine reflected the severity of heart failure, correlating inversely with baseline cardiac index before administration of both drugs. Comparable improvement in left ventricular function was noted after acute therapy. Baseline renin and norepinephrine did not predict the response to prazosin, but baseline renin did predict the response to captopril: pulmonary wedge pressure (r=-0.776, p less than 0.01), stroke index (r=0.752, p less than 0.02), systemic vascular resistance (r=-0.673, p less than 0.05). In summary, elevated levels of plasma norepinephrine were inversely correlated with baseline cardiac function but norepinephrine levels did not change despite improved hemodynamics with specific prazosin therapy. The renin-angiotensin system exhibited a wide spectrum of activity and hemodynamic improvement with captopril was related to this activity. Absence of a correlation between plasma norepinephrine and plasma renin activity suggested that their contributions to vasoconstriction were not interdependent. Increased sympathetic tone was consistent in severe heart failure, whereas renin-angiotensin activity differed widely. The response to captopril can be used to identify a subset of patients with severe heart failure and adverse angiotensin-mediated vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044087     DOI: 10.1016/0002-9149(82)90244-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  Modern treatment of heart failure.

Authors:  A D Timmis
Journal:  BMJ       Date:  1988-07-09

2.  Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.

Authors:  M Packer; N Medina; M Yushak; W H Lee
Journal:  Br Heart J       Date:  1985-09

Review 3.  Pathophysiologic arguments for vasodilators in cardiac failure.

Authors:  A Vogt; K L Neuhaus; H Kreuzer
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 4.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

5.  Mortality in congestive heart failure: effects of vasodilator therapy.

Authors:  A D Timmis
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

6.  Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.

Authors:  Ahmad I M Al-Shafei; R G Wise; G A Gresham; G Bronns; T A Carpenter; L D Hall; Christopher L-H Huang
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

Review 7.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

8.  Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.

Authors:  L Arnolda; B P McGrath; M Cocks; C I Johnston
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 9.  Physiological changes due to age. Implications for drug therapy of congestive heart failure.

Authors:  R J Cody
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

10.  Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.

Authors:  J Bayliss; R Canepa-Anson; M S Norell; P Poole-Wilson; G Sutton
Journal:  Br Heart J       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.